This inventor holds 1 USPTO granted patent. Top assignee: Cold Spring Harbor Laboratory. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Albert S. Mellick: Inventor in Tumor Treatment
Introduction
Albert S. Mellick is an inventor associated with Cold Spring Harbor Laboratory in Huntington, New York. His work includes an invention focused on treating tumors by targeting bone marrow-derived endothelial progenitor cells.
Latest Patents
Mellick is credited with 1 patent: “Treatment of Tumors by Ablating Bone Marrow-Derived Endothelial Progenitor Cells.” The invention describes methods for treating tumors and other conditions characterized by abnormal neoangiogenesis by inhibiting these cells.
Career Highlights
Mellick’s patent reflects research into the role of endothelial progenitor cells in abnormal blood-vessel formation and tumor growth. The disclosed approach aims to address neoangiogenesis by inhibiting cells derived from bone marrow.
Collaborations
Mellick’s listed coworkers include Vivek Mittal and Dingcheng Gao. Their shared association with Cold Spring Harbor Laboratory connects the invention to the institution’s research environment.
Conclusion
Albert S. Mellick’s patent documents an approach to tumor treatment that targets bone marrow-derived endothelial progenitor cells involved in abnormal neoangiogenesis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
